Skip to Content

Office of Research Compliance

How to Register a Clinical Trial

To register your trial on, you must have a username and password. Please submit requests for this information to the Office of Research Compliance. Please give your full name with title, phone number, study title and study sponsor. The coordinator will issue a username and password which will be emailed to you by

Once you have received your username and password, go to to register your trial. The Organization name on the login page is USouthCarolina. A list of all the elements that are required by the law can be found on the Protocol Registration System Information Website. 

When completing your registration, please use the IRB PRO number as the “Study ID number.” This will make it easier for the ORC staff to identify, track, and assist you with questions or requests. 

After completing your registration, please make sure to look it over and make edits in regard to any Warning, Error, or Alert messages that are automatically generated before submitting it for approval and release.

Once you have finished your submission, you must select “Complete” at the top of the protocol record. ORC staff will then receive an email. The submission will be reviewed to make sure all warnings, errors, and alerts are addressed and all applicable notes are addressed. If so, it will be approved and released. If not, the administrator will send you an email asking for edits.

After it is released, will issue a Identifier within 2 to 5 days. To obtain this identifier, go to and search for your study. The identifier is found on the record.

Protocol records for active trials are required to be reviewed and modified as needed at least every 6 months. Pay special attention to recruiting status and contact information as the accuracy and timeliness of this information is extremely important. Remember to update the Record Verification Date field in the registration.

Office of Research Compliance

    Challenge the conventional. Create the exceptional. No Limits.